Myeloma

The Food and Drug Administration granted OM-301 an Orphan Drug Designation for the treatment of patients with myeloma.

A multiple myeloma survivor discusses how continued minimal residual disease negativity made her feel more confident in coming off of maintenance therapy.

I’m more than six years out from my myeloma diagnosis and realized that I’m capable of more than just surviving.

Triplet therapy demonstrates improved remission and survival rates, with manageable side effects for patients who are ineligible for transplant.

Multiple Myeloma Awareness Month is a time to raise awareness both locally and nationally about efforts to fight myeloma.

Patients who used opioids long-term after undergoing an autologous stem cell transplant tended to have poorer survival outcomes, recent research showed.

Carvykti and other drugs prove that there are still options for patients whose myeloma got worse on prior therapies.

The Food and Drug Administration granted an investigational new drug application and green lit the continued study of GC012F for the treatment of patients with relapsed/refractory myeloma.

It came as no surprise that when my mother received a diagnosis of multiple myeloma, she became an advocate for health equity in myeloma.

We simply cannot think of an individual more deserving of recognition as a Multiple Myeloma Health Equity Hero than Yu Mee Song.

Tiffany Williams devoted her career as a pediatric nurse practitioner to addressing health disparities among children and teens. But then, just a year after earning her doctorate, she received a diagnosis of multiple myeloma.

Although there is no cure for myeloma, the prognosis can be good if doctors catch it early.

If you were to meet Dr. Sundar Jagannath in a crowded room, you would not assume that he is one of the greatest myeloma doctors of all time.

Jack Aiello is a leading patient advocate in multiple myeloma on an international level.

Through Dr. Frits van Rhee's patient care and research, he has made a significant impact on improving the lives of those affected by multiple myeloma.

I find myself enormously inadequate to fully explain why I think this lady, my wife, should be selected as a Multiple Myeloma Hero, but whether she is or not, she is my hero.

When I met my myeloma care team, something just clicked, and I knew I was in good hands.

Even with all he has already done, Dr. Landgren continues to study the progression of multiple myeloma, with the goal of stopping progression and finding a cure.

For over 20 years, Dr. Brian Berryman has been a tireless advocate and compassionate care provider for those affected by multiple myeloma.

Dr. J is proactive, creative and practical in planning treatment strategies for his patients. He does not take shortcuts; if the hard way is the right way, then that is what will be done.

My wife, Michelle, has used this diagnosis as a pillar of strength, doing all she can for her young boys and me and leading the best life she can, while along the way committing to raise funds and awareness to help improve and extend the lives of patients with myeloma

At 77 years young, Dr. Huntimerhas been dealing with the cancer world via her own battles with tumors and treatments since she was 22 years old.

Initially, we used my husband's diagnosis to show our support as we navigated this journey and joined a new “club” we really didn’t want to be a part of.

Cynthia Chmielewski is a multiple myeloma hero for many around the world.

He dreams that this ever-growing body of knowledge will progressively improve the ability to understand and treat cancer; multiple myeloma has been at the center of this dream.

Some patients are at higher risk of infection, so it’s critical that they keep their care team up to date on any symptoms.

The past 20 years have brought great advances to advocacy groups, helping to improve patients’ quality of life. But more work is needed to raise awareness in underserved groups.